X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (16) 16
adult (15) 15
male (14) 14
female (11) 11
medicine, research & experimental (11) 11
animals (10) 10
middle aged (10) 10
young adult (10) 10
adenoviruses, simian - genetics (9) 9
parasitic diseases (9) 9
viruses (9) 9
immunization (8) 8
malaria, falciparum - immunology (8) 8
malaria, falciparum - prevention & control (8) 8
genetic vectors (7) 7
malaria vaccines - administration & dosage (7) 7
malaria vaccines - immunology (7) 7
protozoan proteins - immunology (7) 7
vaccination (7) 7
vaccines (7) 7
adenoviruses, simian - immunology (6) 6
adolescent (6) 6
immunogenicity (6) 6
immunology (6) 6
infectious diseases (6) 6
malaria (6) 6
plasmodium falciparum - immunology (6) 6
research article (6) 6
adenoviruses (5) 5
apical membrane antigen-1 (5) 5
biotechnology & applied microbiology (5) 5
drug discovery (5) 5
genetics (5) 5
genetics & heredity (5) 5
immune-responses (5) 5
immunization, secondary (5) 5
malaria vaccine (5) 5
molecular biology (5) 5
molecular medicine (5) 5
original (5) 5
original article (5) 5
pharmacology (5) 5
plasmodium falciparum (5) 5
plasmodium falciparum - genetics (5) 5
t-lymphocytes - immunology (5) 5
vaccinia virus - genetics (5) 5
abridged index medicus (4) 4
adults (4) 4
antibodies (4) 4
article (4) 4
circumsporozoite protein (4) 4
complex mixtures (4) 4
efficacy (4) 4
health aspects (4) 4
immune response (4) 4
immunity (4) 4
in-vitro (4) 4
infection (4) 4
lymphocytes t (4) 4
medical research (4) 4
medicine (4) 4
prime-boost immunization (4) 4
protective immunity (4) 4
protozoan proteins - genetics (4) 4
t cells (4) 4
vaccine (4) 4
virus ankara (4) 4
amino acid sequence (3) 3
antibodies, protozoan - immunology (3) 3
antigens (3) 3
antigens, protozoan - immunology (3) 3
cd8 antigen (3) 3
clinical trials (3) 3
epitopes - immunology (3) 3
flow cytometry (3) 3
immunity, cellular (3) 3
immunoglobulins (3) 3
infections (3) 3
infectious disease (3) 3
interferon-gamma - immunology (3) 3
lymphocytes (3) 3
malaria vaccines - adverse effects (3) 3
malaria vaccines - genetics (3) 3
medicine, experimental (3) 3
microbiology (3) 3
molecular sequence data (3) 3
multidisciplinary sciences (3) 3
naive adults (3) 3
peripheral blood mononuclear cells (3) 3
polymerase-chain-reaction (3) 3
proteins (3) 3
safety (3) 3
science (3) 3
vaccinia virus (3) 3
vector-borne diseases (3) 3
adjuvant vaccines (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibody (2) 2
b cells (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 11/2013, Volume 4, Issue 1, p. 2836
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1635 - 1646
Journal Article
Molecular Therapy, ISSN 1525-0016, 02/2014, Volume 22, Issue 2, pp. 464 - 475
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9693, pp. 912 - 920
Summary Background Stem-cell transplantation can cure primary immunodeficiencies. However, in patients with pre-existing organ toxicity, patients younger than... 
Internal Medicine | TOTAL-BODY IRRADIATION | REDUCED-INTENSITY | MEDICINE, GENERAL & INTERNAL | SEVERE COMBINED IMMUNODEFICIENCY | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | DYSKERATOSIS-CONGENITA | DNA-LIGASE IV | ACUTE MYELOID-LEUKEMIA | MONOCLONAL-ANTIBODIES | NONMALIGNANT DISEASES | Antibodies, Neoplasm - therapeutic use | Graft vs Host Disease - epidemiology | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Infant | Male | Cyclophosphamide - therapeutic use | Transplantation Conditioning - mortality | Antibodies, Monoclonal, Humanized | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Immunologic Deficiency Syndromes - therapy | Kaplan-Meier Estimate | Rats | Treatment Outcome | Vidarabine - analogs & derivatives | Alemtuzumab | Vidarabine - therapeutic use | Transplantation Chimera | Leukocyte Common Antigens - antagonists & inhibitors | Disease-Free Survival | Animals | Graft vs Host Disease - prevention & control | Hematopoietic Stem Cell Transplantation - methods | Immunologic Factors - therapeutic use | Care and treatment | Usage | Patient outcomes | Immunodeficiency | Stem cells | Transplantation | Children | Health aspects | Diseases | Bone marrow | Medical research | Transplants & implants | Mortality | Metabolic disorders | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2012, Volume 205, Issue 5, pp. 772 - 781
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2005, Volume 352, Issue 25, pp. 2598 - 2608
Journal Article
Molecular Therapy, ISSN 1525-0016, 12/2012, Volume 20, Issue 12, pp. 2355 - 2368
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e31208
Background: Traditionally, vaccine development against the blood-stage of Plasmodium falciparum infection has focused on recombinant protein-adjuvant... 
APICAL MEMBRANE ANTIGEN-1 | NATURAL IMMUNE-RESPONSES | VIRUS ANKARA | PRIME-BOOST IMMUNIZATION | IN-VITRO | MEROZOITE SURFACE PROTEIN-1 | BIOLOGY | ADJUVANT VACCINES | RHESUS-MACAQUES | PARASITE GROWTH | MALARIA VACCINE | Immunization | Antigens, Protozoan - immunology | Antibodies, Protozoan - immunology | Humans | Middle Aged | Male | Enzyme-Linked Immunospot Assay | Plasmodium falciparum - immunology | Vaccinia virus - genetics | Genetic Vectors - genetics | Life Cycle Stages | Adenoviruses, Simian - genetics | Young Adult | Antibodies, Neutralizing - immunology | Animals | Interferon-gamma - immunology | Malaria Vaccines - adverse effects | Adolescent | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Adult | Female | T-Lymphocytes - immunology | Plasmodium falciparum - growth & development | Antigens | Medical research | Immune response | Malaria | Immunoglobulin G | Clinical trials | Vaccines | B cells | T cells | Recombinant proteins | Mediation | Infection | Plasmodium falciparum | Genetic vectors | Adenoviruses | Medicine, Experimental | Product development | Health aspects | Laboratories | CD8 antigen | Antibodies | Viruses | Lymphocytes T | Infections | Parasites | Apical membrane antigen 1 | Immunity | Blood | Proteins | Developmental stages | Lymphocytes | Coding | Peripheral blood mononuclear cells | Drug dosages | Recombinant | Formulations | Vector-borne diseases | Phenotypes | Immunoglobulins | Effectiveness | Immune response (cell-mediated) | Vectors | Vectors (Biology) | Immune response (humoral) | CD4 antigen | Medicine | Hospitals | Infectious diseases | Immunogenicity | Alleles | Adults
Journal Article
Molecular Therapy, ISSN 1525-0016, 12/2011, Volume 19, Issue 12, pp. 2269 - 2276
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e115161
Journal Article